Doctor of Pharmacy (Pharm.D.)

Pharmacy
The Ohio State University
2019

Bachelor of Science (B.S.)

Health Science
Long Island University Post
2015

Integrated Therapeutics 6

Integrated Therapeutics 2

NAPLEX/MPJE Readiness

Integrated Therapeutics Lab 1, 2, 3 & 4

Howard University College of Pharmacy Excellence in Teaching Award; 2023-24, 2024-25

Howard University College of Pharmacy C.A.R.E. Recognition Award; 2025

AACP Minority Faculty SIG Outstanding Member Engagement; 2022-23

Retrospective Evaluation of Metabolic Syndrome’s Role in Breast Cancer Outcomes in Black Women

Retrospective Evaluation of Metabolic Syndrome’s Role in Breast Cancer Outcomes in Black Women

Metabolic Syndrome (MS) is a cluster of chronic conditions characterized by the co-occurrence of at least three out of five clinical risk factors: central obesity, hyperglycemia, hypertension, elevated circulating triglycerides, and low high-density lipoprotein (HDL) levels. MS is a well-established precursor to cardiovascular disease and type 2 diabetes mellitus (DM), but emerging evidence also links MS-related pathways, particularly those involving obesity and hyperglycemia, to increased breast cancer (BC) risk and tumor progression. Despite this growing body of literature, there remains a significant gap in understanding the interplay between MS components and BC progression among Black women, a population disproportionately affected by both MS and adverse breast cancer outcomes.

Impact of Removing Race Coefficient from Glomerular Filtration Rate

Impact of Removing Race Coefficient from Glomerular Filtration Rate Estimation Equations on Antidiabetics Among Black Patients

Assessing kidney function through estimated glomerular filtration rate (eGFR) equations plays a crucial role in clinical practice. The estimates are essential for determining appropriate dosages and eligibility for several medications, including antidiabetics. Traditionally, race is used as part of the parameter to estimate kidney function. The modified diet in renal disease (MDRD) equation first introduced the inclusion of race as Black vs. non-Black in 2000. This premise was suggested based on the observation that Black individuals enrolled in the study had a higher level of serum creatinine (SCr) compared with the White counterparts at any given glomerular filtration rate (GFR).

Health Literacy of Patients using Continuous Glucose Monitoring

Health Literacy of Patients using Continuous Glucose Monitoring

Low health literacy and numeracy are associated with poor health outcomes and lower self-efficacy. Continuous glucose monitors (CGMs) can improve diabetes management, but their benefits may be limited by health literacy levels.

Our objective was to characterize health literacy levels of ambulatory care patients using CGMs to manage their diabetes in 1 urban health system. Secondary aims were to identify specific knowledge deficits related to CGM education and determine predictors of self-rated comfort with and understanding of CGM use.

Pharmacists’ Role in Assessing: Food and Health Care Insecurities

Pharmacists’ Role in Assessing: Food and Health Care Insecurities

Social determinants of health (SDOH) encompass the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks. SDOH include food security and health care security, which directly impact patient health and well-being and account for health disparities and inequities.

Potential Agent for Delaying Type 1 Diabetes Mellitus

Potential Agent for Delaying Type 1 Diabetes Mellitus

Type 1 diabetes mellitus (T1DM), an autoimmune disease, affects more than 1 million people in the United States, and approximately 50% of these patients will develop complications related to elevated blood glucose. Currently there are no FDA-approved therapies for delaying the onset or progression of T1DM; however, teplizumab—a monoclonal antibody that has shown efficacy in clinical trials—is being reviewed by the FDA. If it is approved, teplizumab will become the first disease-modifying therapy for T1DM. Because of their high accessibility to patients, pharmacists would be able to engage in early identification of those patients in whom the use of this agent would be most beneficial.

CONFERENCE PRESENTATIONS

• CGM Pharmacotherapy & Recent Updates in Diabetes Management
  • CE Presentation: Howard University College of Pharmacy License Renewal CE Program. Washington, DC February 2025
• New Considerations in Diabetes Management: The Role of Continuous Glucose Monitors & The Risk of Euglycemic Diabetic Ketoacidosis (eDKA)
  • ACPE CE Presentation: American College of Clinical Pharmacy Conference; Phoenix, AZ October 2024
• Preparing for Tomorrow Through Continuous Glucose Monitors
  • ACPE CE Presentation: National Pharmaceutical Association; Los Angeles, CA August 2024
• Impostor Phenomenon among Minoritized Students July 2023
  • American Association of Colleges of Pharmacy National Conference; Aurora, CO
• Is it Professionalism or Professional Identity? July 2022
  • American Association of Colleges of Pharmacy National Conference; Grapevine, TX